MPO is involved in CVD processes in many ways, contributing to the oxidation of LDL [109], the impairment of high-density lipoprotein (HDL) function, the reduction in nitric oxide (NO) bioavailability leading to endothelial dysfunction [110], and the activation of matrix metalloproteinases (MMPs) [111]. This evidence concerns the gene MPO and endothelial dysfunction.